• 1
    de Gasparo M, Catt KJ, Inagami T et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415472.
  • 2
    Busche S, Gallinat S, Bohle RM et al. Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study. Am J Pathol 2000; 157: 605611.
  • 3
    Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99: 19261935.
  • 4
    Adachi Y, Saito Y, Kishimoto I et al. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 2003; 107: 24062408.
  • 5
    Kaschina E, Grzesiak A, Li J et al. Angiotensin II type 2 receptor stimulation: A novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 2008; 118: 25232532.
  • 6
    Tsutsumi Y, Matsubara H, Ohkubo N et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998; 83: 10351046.
  • 7
    Matsumoto T, Ozono R, Oshima T et al. Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure. Cardiovasc Res 2000; 46: 7381.
  • 8
    Nio Y, Matsubara H, Murasawa S et al. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95: 4654.
  • 9
    Mukoyama M, Nakajima M, Horiuchi M et al. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993; 268: 2453924542.
  • 10
    Li J, Culman J, Hortnagl H et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 2005; 19: 617619.
  • 11
    Lucius R, Gallinat S, Rosenstiel P et al. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 1998; 188: 661670.
  • 12
    Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763776.
  • 13
    Assmus B, Schachinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 30093017.
  • 14
    Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968973.
  • 15
    Kajstura J, Rota M, Whang B et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005; 96: 127137.
  • 16
    Fazel S, Cimini M, Chen L et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006; 116: 18651877.
  • 17
    Wan Y, Wallinder C, Plouffe B et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004; 47: 59956008.
  • 18
    Ribble D, Goldstein NB, Norris DA et al. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 2005; 5: 12.
  • 19
    Kajstura J, Cigola E, Malhotra A et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29: 859870.
  • 20
    Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000; 182: 311322.
  • 21
    Grépin C, Robitaille L, Antakly T et al. Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol Cell Biol 1995; 15: 40954102.
  • 22
    Rutenberg JB, Fischer A, Jia H et al. Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development 2006; 133: 43814390.
  • 23
    Stoll M, Steckelings UM, Paul M et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651657.
  • 24
    Nakajima M, Hutchinson HG, Fujinaga M et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995; 92: 1066310667.
  • 25
    Tsuzuki S, Matoba T, Eguchi S et al. Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension 1996; 28: 916918.
  • 26
    Ohkubo N, Matsubara H, Nozawa Y et al. Angiotensin type 2 receptors are Reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997; 96: 39543962.
  • 27
    Côté F, Do TH, Laflamme L et al. Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J Biol Chem 1999; 274: 3168631692.
  • 28
    Kilian P, Campbell S, Bilodeau L et al. Angiotensin II Type 2 receptor stimulation increases the rate of NG108–15 cell migration via actin depolymerization. Endocrinology 2008; 149: 29232933.
  • 29
    Urbanek K, Quaini F, Tasca G et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003; 100: 1044010445.
  • 30
    Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004; 364: 141148.
  • 31
    Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the Randomized, Controlled Boost (Bone Marrow Transfer To Enhance ST-elevation Infarct Regeneration) Trial. Circulation 2006; 113: 12871294.
  • 32
    Saraste A, Pulkki K, Kallajoki M et al. Apoptosis in human acute myocardial infarction. Circulation 1997; 95: 320323.
  • 33
    Iwanami J, Mogi M, Li J-M et al. Deletion of Angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke 2008; 39: 25542559.
  • 34
    Matsui T, Li L, del Monte F et al. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999; 100: 23732379.
  • 35
    Suleman N, Somers S, Smith R et al. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res 2008; 79: 127133.
  • 36
    Burchfield JS, Iwasaki M, Koyanagi M et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 2008; 103: 203211.
  • 37
    Ebelt H, Jungblut M, Zhang Y et al. Cellular cardiomyoplasty: Improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 2007; 25: 236244.